Jaroslaw P. Maciejewski - Publications, H-index & Citations

Jaroslaw P. Maciejewski

cleveland clinic

106H指数

1.5K论文数

4.3W被引数

收录论文 263

发表时间

Impact of Response to Hypomethylating Agent-Based Therapy on Survival Outcomes in the Context of Baseline Clinical-Molecular Risk and Transplant Status in Patients With Higher-Risk Myelodysplastic Syndromes/Neoplasms: An analysis From the International Consortium for MDS (icMDS)基于低甲基化制剂治疗的反应对高风险骨髓增生异常综合征/肿瘤患者生存结局的影响：考虑基线临床-分子风险和移植状态的国际骨髓增生异常综合征联盟(icMDS)分析

American Journal of Hematology

IF9.9

2026-08-28

PREAI

Benjamin Rolles; Jan Philipp Bewersdorf; Tariq Kewan; Ondrej Blaha; Jessica M. Stempel; Luca Lanino; Najla H. Al Ali; Amy E. DeZern; Mikkael A. Sekeres; Geoffrey L. Uy; Samuel Urrutia; Hetty E. Carraway; Pinkal Desai; Elizabeth A. Griffiths; Eytan M. Stein; Andrew M. Brunner; Christine McMahon; Rory M. Shallis; Joshua F. Zeidner; Michael R. Savona; Shougat Barua; Namrata Sonia Chandhok; Constantine Logothetis; Aram Bidikian; Ted M. Getz; Gail J. Roboz; Eunice S. Wang; Amyah C. Harris; Maria L. Amaya; Hayley Hawkins; Somedeb Ball; Justin Grenet; Parisa Abedi; Shai Shimony; R. Coleman Lindsley; Zhuoer Xie; Yazan F. Madanat; Yasmin Abaza; Talha Badar; Torsten Haferlach; Jaroslaw P. Maciejewski; David Sallman; Anoop Enjeti; Kamal Al-Rabi; Khalid Halahleh; Devendra Hiwase; Maria Diez-Campelo; David Valcarcel; Claudia Haferlach; Lisa Pleyer; Ioannis Kotsianidis; Vasiliki Pappa; Valeria Santini; Angela Consagra; Aref Al-Kali; Seishi Ogawa; Yasuhito Nannya; Matteo Giovanni Della Porta; Rami S. Komrokji; Amer M. Zeidan; Maximilian Stahl

Multilineage lymphoid clonal hematopoiesis: a cross-sectional, correlative analysis of plasma cell dyscrasias and large granular lymphocytic leukemia 多系谱系淋巴细胞克隆性造血：浆细胞异常和大型颗粒淋巴细胞白血病的横断面相关性分析

Leukemia

IF13.4

2026-08-05

OAAI

Carlos Bravo-Perez; Carmelo Gurnari; Arda Durmaz; Miguel Ruiz; Zachary Braunstein; Naomi Kawashima; Justin Jiang; Zachary Brady; Atsushi Marumo; Arooj Ahmed; Mark Orland; Aashray Mandala; Luca Guarnera; Matteo D’Addona; Serhan Unlu; Christopher Haddad; Kartik Lakhotiya; Praveena Thiagarajan; Megan Nakashima; Heesun J. Rogers; Jonathan E. Brammer; Valeria Visconte; Jaroslaw P. Maciejewski

Molecular and clinical analyses of c-CBL mutations affecting tyrosine 371 in myelodysplastic and proliferative disorders c-CBL基因中影响酪氨酸371突变的分子和临床分析在骨髓增生异常和增殖性疾病中的应用

Leukemia

IF13.4

2026-07-22

OAAI

Luca Guarnera; Carmelo Gurnari; Zachary Brady; Carlos Bravo-Perez; Matteo D’Addona; Atsushi Marumo; Mark Orland; Praveena Thiagarajan; Serhan Unlu; Christopher Haddad; Aashray Mandala; Eleonora Lumia; Nicole Lelli; Arda Durmaz; Emiliano Fabiani; Maria Teresa Voso; Jaroslaw P. Maciejewski; Valeria Visconte

High-resolution single-cell mapping of clonal hematopoiesis and structural variation in aplastic anemia 再生障碍性贫血中克隆造血和结构变异的高分辨率单细胞定位

Nature Genetics

IF29

2026-05-01

PREAI

Masanori Yoshida; Sushree S. Sahoo; Paula Y. Arnold; Carmelo Gurnari; Anaïs J. C. N. van Leeuwen; Limeng Pu; Markus J. van Roosmalen; Ti-Cheng Chang; Charnise Goodings; Rashid Mehmood; Lucca L. M. Derks; Nathan Gray; Michelle Boals; Sara Lewis; Lili Kotmayer; Cristyn N. Branstetter; Swapna Thota; Joshua Leow; Wenchao Zhang; Yichao Li; Melanie R. Loyd; Granger Ridout; Emily V. Walker; Christy W. LaFlamme; Heather C. Mefford; Zachary Brady; Yash B. Shah; Rheanna G. Congdon; Miriam Erlacher; Brigitte Strahm; Ayami Yoshimi; Shinsuke Hirabayashi; Helen D. Reed; Akiko Shimamura; Guolian Kang; Xiang Chen; Jinghui Zhang; Charlotte M. Niemeyer; Joseph H. Oved; Timothy S. Olson; Ruben van Boxtel; Jaroslaw P. Maciejewski; Daria V. Babushok; Marcin W. Wlodarski

Defining remission and relapse after allogeneic hematopoietic cell transplantation in myelodysplastic/myeloproliferative neoplasms and optimization of transplantation outcomes: Recommendations from the EBMT practice harmonisation and guidelines committee 定义异基因造血细胞移植后骨髓增生异常/骨髓增生性肿瘤的缓解和复发，并优化移植结果：EBMT实践协调与指南委员会的建议

Bone Marrow Transplantation

IF5.2

2026-04-01

PREAI

Christopher Armstrong; Kavita Raj; Giorgia Battipaglia; Gonzalo Bentolila; Eolia Brissot; Yves Chalandon; Fernando Barroso Duarte; Joanna Drozd-Sokolowska; Vaneuza Funke; Nico Gagelmann; Thierry Guillaume; Carmelo Gurnari; Robert Hasserjian; Juan Carlos Hernández-Boluda; Devendra Hiwase; Andrés Jerez; Michael Loschi; Marin Medjugorac; Mufaddal T. Moonim; Francesco Onida; Nicola Polverelli; Micaela Quarchioni; Marie Robin; Christof Scheid; Katja Sockel; Daniel H. Wiseman; Annalisa Ruggeri; Isabel Sánchez-Ortega; Natalia Aranguiz Garcia; Mario Cazzola; Fabio Ciceri; Tomasz Czerw; Jaroslaw Maciejewski; Simona Pagliuca; Lisa Pleyer; Patryk Sobieralski; Jurjen Versluis; Maria Teresa Voso; Ibrahim Yakoub-Agha; Donal P. McLornan

DDX41-mutant myeloid neoplasms defy current prognostic schemes and require a dedicated risk scoring system: a multicenter, retrospective study DDX41突变髓系肿瘤挑战现有的预后方案，并需要专门的危险评分系统：一项多中心、回顾性研究

Leukemia

IF13.4

2025-12-03

PREAI

Carmelo Gurnari; Hideki Makishima; Arda Durmaz; Enrico Attardi; Ryunosuke Saiki; Alex Bataller; Guilherme Sapinho; Lukasz Gondek; Yasuhito Nannya; Steve Best; Pramila Krishnamurthy; Kar Lok Kong; Yoshiko Atsuta; Senji Kasahara; Kazuma Ohyashiki; Yasushi Miyazaki; Nobuhiro Kanemura; Nobuhiro Hiramoto; Francesco Versino; Maria Julia Montoro; Sara Torres-Esquius; Andres Jerez Cayuela; Miguel López-Esteban; Carolina Martínez-Laperche; Hussein Awada; Valeria Visconte; Courtney D. DiNardo; Maria Teresa Voso; Amy E. DeZern; Guillermo Garcia-Manero; Austin G. Kulasekararaj; Jaroslaw P. Maciejewski; Seishi Ogawa

Molecular Insights and Therapeutic Advances in Low-Risk Myelodysplastic Neoplasms: A Clinical Review 低风险骨髓增生异常性肿瘤的分子洞察与治疗进展：临床综述

Cancers 2025, Vol. 17, Page 3610

IF4.4

2025-11-09

OAAI

Vikram Dhillon; Jaroslaw Maciejewski; Suresh Kumar Balasubramanian

Telomere content and genomics of myeloid neoplasia by WGS 端粒含量和髓系肿瘤的全基因组测序（WGS）基因组学

Blood

IF23.1

2025-09-24

OAAI

Luca Guarnera; Adam Wahida; Carmelo Gurnari; Stephan Hutter; Sabine A. Stainczyk; Nakisha D. Williams; Arda Durmaz; Yasuo Kubota; Carlos Bravo-Perez; Naomi Kawashima; Mark Orland; Simona Pagliuca; Yimin Huang; Thomas LaFramboise; Valeria Visconte; Wencke Walter; Manja Meggendorfer; Wolfgang Kern; Frank Westermann; Lars Feuerbach; Torsten Haferlach; Jaroslaw P. Maciejewski

C-CBL MUTATIONS AFFECTING RESIDUE 371 ARE INDEPENDENTLY CORRELATED WITH DISMAL PROGNOSIS IN MDS AND CMML GUIDED POSTER VIEWING SESSION 1: THERAPY-PART I 影响371位残基的C-CBL突变在MDS和CMML中与不良预后独立相关指导的海报观看会1：治疗-第一部分

LEUKEMIA RESEARCH

IF2.2

2025-09-01

PREAI

Guarnera, Luca; Gurnari, Carmelo; Brady, Zachary; Bravo-Perez, Carlos; Durmaz, Arda; Addona, Matteo D.; Orland, Mark; Thiagarajan, Praveena; Unlu, Serhan; Haddad, Christopher; Mandala, Aashray; Fabiani, Emiliano; Voso, Maria Teresa; Maciejewski, Jaroslaw; Visconte, Valeria

TELOMERE CONTENT IN MYELOID NEOPLASIA COULD INFORM ON DIFFERENTIAL SENSITIVITY TO TELOMERASE INHIBITORS 髓系肿瘤中的端粒含量可能提示对端粒酶抑制剂的差异性敏感性

LEUKEMIA RESEARCH

IF2.2

2025-09-01

PREAI

Guarnera, Luca; Wahida, Adam; Gurnari, Carmelo; Hutter, Stephan; Stainczyk, Sabine; Williams, Nakisha; Durmaz, Arda; Kubota, Yasuo; Bravo-Perez, Carlos; Kawashima, Naomi; Pagliuca, Simona; Huang, Yimin; Laframboise, Thomas; Visconte, Valeria; Walter, Wencke; Meggendorfer, Manja; Kern, Wolfgang; Westermann, Frank; Feuerbach, Lars; Haferlach, Torsten; Maciejewski, Jaroslaw

LOSS OF TET2 IMPAIRS DNA MISMATCH REPAIR EFFICIENCY RESULTING IN CLONALLY RESTRICTED GENOMIC INSTABILITY TET2缺失损害DNA错配修复效率，导致克隆性限制的基因组不稳定性

LEUKEMIA RESEARCH

IF2.2

2025-09-01

PREAI

Jiang, Dongxu; Zhang, Yahan; Gu, Xiaorong; Vail, Daniel; Khan, Raziullah; Visconte, Valeria; Maciejewski, Jaroslaw; Jha, Babal

Oral iptacopan monotherapy in paroxysmal nocturnal haemoglobinuria: final 48-week results from the open-label, randomised, phase 3 APPLY-PNH trial in anti-C5-treated patients and the open-label, single-arm, phase 3 APPOINT-PNH trial in patients previously untreated with complement inhibitors 口服iptacopan单药治疗阵发性夜间血红蛋白尿症：来自在抗C5治疗患者中进行的开放标签、随机、III期APPLY-PNH试验和既往未经补体抑制剂治疗的患者的开放标签、单臂、III期APPOINT-PNH试验的最终48周结果

lancet haematology

IF0

2025-05-28

PREAI

Antonio M Risitano; Austin G Kulasekararaj; Phillip Scheinberg; Alexander Röth; Bing Han; Jaroslaw P Maciejewski; Yasutaka Ueda; Carlos M de Castro; Eros Di Bona; Rong Fu; Li Zhang; Morag Griffin; Saskia M C Langemeijer; Jens Panse; Hubert Schrezenmeier; Wilma Barcellini; Vitor A Q Mauad; Philippe Schafhausen; Suzanne Tavitian; Eloise Beggiato; Régis Peffault de Latour

Elderly Patients With Aplastic Anemia: Treatment Patterns and Outcomes in the Real World 老年再生障碍性贫血患者：真实世界中的治疗模式与结局

AMERICAN JOURNAL OF HEMATOLOGY

IF9.9

2025-01-29

OAAI

Fattizzo, B; Gurnari, C; Giammarco, S; Ricchiuti, A; Awada, H; Bortolotti, M; Galli, N; Pedone, GL; Versino, F; Consonni, D; Trikha, R; Gandhi, S; Sica, S; Maciejewski, JP; Kulasekararaj, A; Barcellini, W

Clonal hematopoiesis in large granular lymphocytic leukemia

LEUKEMIA

IF13.4

2024-11-21

PREAI

Kawashima, Naomi; Gurnari, Carmelo; Bravo-Perez, Carlos; Kubota, Yasuo; Pagliuca, Simona; Guarnera, Luca; Williams, Nakisha D.; Durmaz, Arda; Ahmed, Arooj; Dima, Danai; Ullah, Fauzia; Carraway, Hetty E.; Singh, Abhay; Visconte, Valeria; Maciejewski, Jaroslaw P.

Clinical Significance of HOX and Meis gene Expression Profiling in Acute Myeloid Leukemia 急性髓系白血病中HOX和Meis基因表达谱的临床意义

BLOOD

IF23.1

2024-11-05

PREAI

Dhillon, Vikram; Aguilar, Jeff; Kim, Paul; Padmanabhan, Dakshin; Dhiman, Sandhya; Dyson, Gregory; Maciejewski, Jaroslaw; Balasubramanian, Suresh Kumar

Identification of Tumor Suppressors and Synthetic Lethal Targets in-7/del7q Myeloid Neoplasms By Iterative Computational Analysis Coupled with Experimental Validation 通过迭代计算分析与实验验证相结合的方法，鉴定7号染色体单体缺失型骨髓性肿瘤中的肿瘤抑制因子和合成致死靶点

BLOOD

IF23.1

2024-11-05

PREAI

Vail, Daniel J.; Visconte, Valeria; Jha, Babal K.; Durkin, Jill; Maciejewski, Jaroslaw; Laframboise, Thomas

Genetic Profiling and Survival Analysis of Patients with Acute Myeloid Leukemia and a History of Autoimmune Disease 急性髓系白血病患者伴自身免疫性疾病史的基因分型与生存分析

BLOOD

IF23.1

2024-11-05

PREAI

Udoh, Eno-Obong B.; Philip, Sarah J.; Visconte, Valeria; Chen, Xiaoying; Wei, Wei; Sawalha, Yazeed; Madanat, Yazan F.; Rose, Ameera; Kuzmanovic, Teodora; Sobecks, Ronald; Hamilton, Betty K.; Mukherjee, Sudipto; Gerds, Aaron T.; Carraway, Hetty E.; Maciejewski, Jaroslaw; Sekeres, Mikkael A.; Molina, John C.; Ali, Moaath K. Mustafa; Jain, Akriti G.; Singh, Abhay; Balderman, Sophia; Advani, Anjali S.

Targeting Poly(U) Binding Splicing Factor 60 (PUF60): A Small-Molecule Inhibitor Shows Anti-Leukemic Activity and Impacts Cell Cycle in Leukemia Models 靶向Poly(U)结合剪接因子60 (PUF60): 一种小分子抑制剂显示出抗白血病活性并影响白血病模型中的细胞周期

BLOOD

IF23.1

2024-11-05

PREAI

Yuan, Xinrui; Sabzvar, Mona Kazemi; Patil, Amol; Durmaz, Arda; Maciejewski, Jaroslaw; Visconte, Valeria; Yang, Chao-Yie

Loss of TET2 Creates a Distinct Immunopeptidome in Acute Myeloid Leukemia TET2的缺失在急性髓系白血病中创造了一个独特的免疫肽组。

BLOOD

IF23.1

2024-11-05

PREAI

Gu, Xiaorong; Zhang, Yahan; Bae, Songa; Jiang, Dongxu; Vail, Daniel; Schlanger, Simon; Maciejewski, Jaroslaw; Jha, Babal K.

Developing a Therapeutic Strategy for Targeting Metabolic Vulnerability of TET2 Mutant Leukemia 开发针对TET2突变白血病代谢脆弱性的治疗策略

BLOOD

IF23.1

2024-11-05

PREAI

Gu, Xiaorong; Zhang, Yahan; Bae, Songa; Jiang, Dongxu; Williams, Nakisha; Vail, Daniel; Schlanger, Simon; Durkin, Jill; Parker, Yvonne; Lindner, Daniel; Maciejewski, Jaroslaw; Jha, Babal K.

研究方向